DK1326592T3 - Anvendelse af polyethylenglycol (PEG) til fremstilling af et lægemiddel til behandling af forstoppelse - Google Patents

Anvendelse af polyethylenglycol (PEG) til fremstilling af et lægemiddel til behandling af forstoppelse

Info

Publication number
DK1326592T3
DK1326592T3 DK01975466T DK01975466T DK1326592T3 DK 1326592 T3 DK1326592 T3 DK 1326592T3 DK 01975466 T DK01975466 T DK 01975466T DK 01975466 T DK01975466 T DK 01975466T DK 1326592 T3 DK1326592 T3 DK 1326592T3
Authority
DK
Denmark
Prior art keywords
peg
polyethylene glycol
constipation
drug
manufacture
Prior art date
Application number
DK01975466T
Other languages
Danish (da)
English (en)
Inventor
Russell W Pelham
Mark Vb Cleveland
Original Assignee
Braintree Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Braintree Lab filed Critical Braintree Lab
Application granted granted Critical
Publication of DK1326592T3 publication Critical patent/DK1326592T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Electrotherapy Devices (AREA)
DK01975466T 2000-09-28 2001-09-27 Anvendelse af polyethylenglycol (PEG) til fremstilling af et lægemiddel til behandling af forstoppelse DK1326592T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/675,105 US6645481B1 (en) 2000-09-28 2000-09-28 Method of achieving overnight laxation and control of bowel function
PCT/US2001/030227 WO2002026222A2 (en) 2000-09-28 2001-09-27 Method of achieving overnight laxation and control of bowel function

Publications (1)

Publication Number Publication Date
DK1326592T3 true DK1326592T3 (da) 2008-11-10

Family

ID=24709076

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01975466T DK1326592T3 (da) 2000-09-28 2001-09-27 Anvendelse af polyethylenglycol (PEG) til fremstilling af et lægemiddel til behandling af forstoppelse

Country Status (12)

Country Link
US (1) US6645481B1 (de)
EP (1) EP1326592B1 (de)
AT (1) ATE401900T1 (de)
AU (1) AU2001294790A1 (de)
CA (1) CA2423746A1 (de)
CY (1) CY1110052T1 (de)
DE (1) DE60135001D1 (de)
DK (1) DK1326592T3 (de)
ES (1) ES2310190T3 (de)
PT (1) PT1326592E (de)
SI (1) SI1326592T1 (de)
WO (1) WO2002026222A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7291324B2 (en) * 2002-10-22 2007-11-06 Braintree Laboratories Inc. Method of bowel cleansing
AU2004290580A1 (en) * 2003-11-17 2005-06-02 Braintree Laboratories, Inc. Therapeutic PEG solution concentrate
US7687075B2 (en) 2003-11-19 2010-03-30 Salix Pharmaceuticals, Ltd. Colonic purgative composition with soluble binding agent
US7256202B2 (en) * 2003-12-31 2007-08-14 Halow George M Composition and method for treatment of hepatic encephalopathy
US20050244368A1 (en) * 2004-04-29 2005-11-03 Pashankar Dinesh S Pre-endoscopic use of polyethylene glycol compositions
US20060247180A1 (en) * 2005-04-29 2006-11-02 Bergey James L Purgative composition and uses thereof
WO2006118562A1 (en) * 2005-04-29 2006-11-09 Inkine Pharmaceutical Company, Inc. Purgative composition and uses thereof
US7495063B2 (en) * 2006-02-03 2009-02-24 Dow Global Technologies Inc. Reduced oligomer concentration in high purity polyalkylene glycols
WO2014144407A1 (en) 2013-03-15 2014-09-18 Braintree Laboratories, Inc. Dual use oral pharmaceutical composition tablets of sulfate saltes and methods of use thereof
CA2947434A1 (en) 2014-04-29 2015-11-05 Colonaryconcepts Llc Foods, systems, methods, and kits for providing electrolyte replacement
WO2016140981A1 (en) 2015-03-02 2016-09-09 Colonaryconcepts Llc Compounds and methods for peg metabolite and peg breakdown product assays

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5710183A (en) 1995-07-14 1998-01-20 Halow; George M. Laxative/antidiarrheal composition comprising polyethylene glycol and fiber bulking agent
US6048901A (en) * 1999-04-20 2000-04-11 Braintree Laboratories, Inc. Method of reducing intestinal gas, cramping and anorectal irritation

Also Published As

Publication number Publication date
PT1326592E (pt) 2008-10-20
DE60135001D1 (de) 2008-09-04
AU2001294790A1 (en) 2002-04-08
ATE401900T1 (de) 2008-08-15
US6645481B1 (en) 2003-11-11
WO2002026222A8 (en) 2002-06-27
WO2002026222A2 (en) 2002-04-04
CA2423746A1 (en) 2002-04-04
CY1110052T1 (el) 2015-01-14
ES2310190T3 (es) 2009-01-01
EP1326592B1 (de) 2008-07-23
EP1326592A1 (de) 2003-07-16
SI1326592T1 (sl) 2009-02-28

Similar Documents

Publication Publication Date Title
CY1110052T1 (el) Η χρηση της πολυαιθυλενογλυκολης (peg) για την κατασκευη φαρμακου για τη θεραπεια της δυσκοιλιοτητας
ATE460921T1 (de) Medikamenthaltige zusammensetzung in aerosolform
BR0109943A (pt) Composições farmacêuticas
HUT77944A (hu) Ondansetront tartalmazó, orálisan beadható, folyékony gyógyszerkészítmény
DK1157037T3 (da) GCSF-konjugater
BE2015C026I2 (en) 2-phenyl-1-[-(2-aminoethoxy)-benzyl -indole in combination with estrogens
DK1257254T3 (da) Formuleringer indeholdende et anticholinergt lægemiddel til behandling af kronisk obstruktiv lungesygdom
ATE411007T1 (de) Gegen missbrauch gesicherte darreichungsform
EP1048297A3 (de) Verwendung von Polyethylenglykol zur Verminderung von Darmgasen, Krämpfen und Anorektalereizung
SE0102843L (sv) Stabiliserad oral farmaceutisk komposition innehållande jodid och jodat och metod
SE0101932D0 (sv) Pharmaceutical combinations
TNSN04034A1 (en) Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
DE602004005564D1 (de) Pharmazeutische Zusammensetzung für Thrombinpeptidderivaten
ATE243196T1 (de) Piperidine und pyrrolidine
DE60239752D1 (de) Den geschmack verdeckende auslaufsichere formulierung
EA200901393A1 (ru) Фармацевтическая композиция, содержащая гестагены и/или эстрогены и 5 метил-(6s)-тетрагидрофолат
IS5851A (is) Ný lyf til inntöku 5-HT4 gerandefna eða mótlyfja
EP1354602A4 (de) Medizinische zusammensetzungen mit diuretischem und die insulinresistenz verbesserndem mittel
EE200200087A (et) Kompositsioon hepatotsellulaarse kartsinoomi raviks
DE60202590D1 (de) 2h-1-benzopyran-derivate, prozesse zu ihrer herstellung und pharmazeutische zusammensetzungen
MA22343A1 (fr) Compositions type massepain, contenant du psyllium
SE0001916D0 (sv) Novel formulation
NO20032411L (no) Anvendelse av substituerte 6-dimetylaminometyl-1-fenyl- cykloheksan-forbindelser for behandling av urininkontinens
DK1061938T3 (da) Orale sammensætninger med cytotoksiske proteiner i lav dosis
HRP20040165B1 (hr) Upotreba citaloprama u liječenju povišenog krvnogtlaka